Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.040
-0.030 (-2.80%)
Nov 20, 2024, 4:00 PM EST - Market closed

Co-Diagnostics Statistics

Total Valuation

Co-Diagnostics has a market cap or net worth of $33.21 million. The enterprise value is -$2.09 million.

Market Cap 33.21M
Enterprise Value -2.09M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

Co-Diagnostics has 31.93 million shares outstanding. The number of shares has increased by 2.06% in one year.

Current Share Class 31.93M
Shares Outstanding 31.93M
Shares Change (YoY) +2.06%
Shares Change (QoQ) +1.23%
Owned by Insiders (%) 5.40%
Owned by Institutions (%) 14.05%
Float 30.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 4.26
Forward PS 86.82
PB Ratio 0.52
P/TBV Ratio 0.88
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.92, with a Debt / Equity ratio of 0.04.

Current Ratio 6.92
Quick Ratio 6.53
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -50.57% and return on invested capital (ROIC) is -29.64%.

Return on Equity (ROE) -50.57%
Return on Assets (ROA) -27.61%
Return on Capital (ROIC) -29.64%
Revenue Per Employee $47,232
Profits Per Employee -$266,350
Employee Count 155
Asset Turnover 0.08
Inventory Turnover 1.28

Taxes

In the past 12 months, Co-Diagnostics has paid $3.90 million in taxes.

Income Tax 3.90M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -24.64% in the last 52 weeks. The beta is -0.85, so Co-Diagnostics's price volatility has been lower than the market average.

Beta (5Y) -0.85
52-Week Price Change -24.64%
50-Day Moving Average 1.22
200-Day Moving Average 1.22
Relative Strength Index (RSI) 30.65
Average Volume (20 Days) 90,878

Short Selling Information

The latest short interest is 208,704, so 0.65% of the outstanding shares have been sold short.

Short Interest 208,704
Short Previous Month 226,426
Short % of Shares Out 0.65%
Short % of Float 0.69%
Short Ratio (days to cover) 2.63

Income Statement

In the last 12 months, Co-Diagnostics had revenue of $7.32 million and -$41.28 million in losses. Loss per share was -$1.38.

Revenue 7.32M
Gross Profit 3.61M
Operating Income -40.00M
Pretax Income -35.81M
Net Income -41.28M
EBITDA -38.67M
EBIT -40.00M
Loss Per Share -$1.38
Full Income Statement

Balance Sheet

The company has $37.66 million in cash and $2.37 million in debt, giving a net cash position of $35.29 million or $1.11 per share.

Cash & Cash Equivalents 37.66M
Total Debt 2.37M
Net Cash 35.29M
Net Cash Per Share $1.11
Equity (Book Value) 63.78M
Book Value Per Share 2.00
Working Capital 34.31M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.70 million and capital expenditures -$1.14 million, giving a free cash flow of -$26.84 million.

Operating Cash Flow -25.70M
Capital Expenditures -1.14M
Free Cash Flow -26.84M
FCF Per Share -$0.84
Full Cash Flow Statement

Margins

Gross Margin 49.30%
Operating Margin -546.37%
Pretax Margin -510.65%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -287.51%

Dividends & Yields

Co-Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.06%
Shareholder Yield -2.06%
Earnings Yield -124.32%
FCF Yield -80.83%

Analyst Forecast

The average price target for Co-Diagnostics is $1.50, which is 44.23% higher than the current price. The consensus rating is "Hold".

Price Target $1.50
Price Target Difference 44.23%
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Co-Diagnostics has an Altman Z-Score of 1.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.07
Piotroski F-Score 2